Acrs stock zacks

Stock quote for Aclaris Therapeutics, Inc. Common Stock Common Stock (ACRS) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Aclaris (ACRS) Upgraded to Buy: Here's What You Should Know Aug 21, 2019 · Aclaris (ACRS) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Aclaris (ACRS) Upgraded to Buy: Here's Why Dec 24, 2019 · Investors might want to bet on Aclaris Therapeutics (ACRS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. Finance - Zacks - Zacks Investment Research The Zacks Personal Finance Channel provides guidance about investing, insurance, retirement planning and taxes so readers can make informed decisions about their financial futures. ACRS Earnings Date, Forecast and Report (Aclaris Therapeutics)

ACRS has been the topic of a number of recent analyst reports. Zacks Investment Research cut shares of Aclaris Therapeutics from a “hold” rating to a “sell” rating in a research note on Thursday, February 27th. SVB Leerink reaffirmed an “outperform” rating on shares of Aclaris Therapeutics in a research note on Thursday, January 2nd.

All News for ACRE - Zacks Investment Research Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. Aclaris Therapeutics, Inc. (ACRS) Stock Analysis & News ... Get breaking news and analysis on Aclaris Therapeutics, Inc. (ACRS) stock, price quote and chart, trading and investing tools. at Zacks.com (Dec 24, 2019) Aclaris Therapeutics (ACRS) May ACRS Stock Price | Aclaris Therapeutics Inc. Stock Quote ... ACRS | Complete Aclaris Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Aclaris Therapeutics, Inc. (ACRS) Stock Price, Quote ...

Mar 27, 2020 · ACRS's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

All News for ACRE - Zacks Investment Research Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. Aclaris Therapeutics, Inc. (ACRS) Stock Analysis & News ... Get breaking news and analysis on Aclaris Therapeutics, Inc. (ACRS) stock, price quote and chart, trading and investing tools. at Zacks.com (Dec 24, 2019) Aclaris Therapeutics (ACRS) May ACRS Stock Price | Aclaris Therapeutics Inc. Stock Quote ... ACRS | Complete Aclaris Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Aclaris Therapeutics, Inc. (ACRS) Stock Price, Quote ...

ACRS: Aclaris Therapeutics, Inc. broker recommendations. Get the latest broker recommendations from Zacks Investment Research.

ACRS investment & stock information. Get the latest Aclaris Therapeutics, Inc. ACRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Lags Revenue ...

Aclaris Therapeutics (ACRS) May Report Negative Earnings ... Oct 29, 2019 · Aclaris Therapeutics, Inc. (ACRS): Free Stock Analysis Report To read this article on Zacks.com click here. The views and opinions expressed herein are … Aclaris (ACRS) Upgraded to Buy: Here's Why Apr 06, 2020 · Aclaris (ACRS) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Jan 10, 2020 · As reported by Zacks, the current mean recommendation for DERM is in the "buy range". Aclaris Therapeutics, Inc. ( ACRS) is +0.52 at $2.38, with 957,330 shares traded. As reported in the last short interest update the days to cover for ACRS is 10.706505; this calculation is based on the average trading volume of the stock. ACRS - Aclaris Therapts Stock Analyst Ratings - Barchart.com Analyst Ratings for Aclaris Therapts (ACRS) provide recommendations made by outside industry experts. Barchart provides Analyst Ratings to give you another tool to gauge the possible future performance of a stock. Analyst Ratings are available for US and Canadian equities. The Ratings Breakdown table uses Zacks' brokerage Pre-Market Earnings Report for March 18, 2019 : OSTK, LL ... Mar 15, 2019 · Zacks Investment Research reports that the 2018 Price to Earnings ratio for ACRS is -1.49 vs. an industry ratio of -4.60, implying that they will have a higher earnings growth than their Analysts Anticipate Aclaris Therapeutics Inc (NASDAQ:ACRS ... Apr 07, 2020 · Equities analysts expect that Aclaris Therapeutics Inc (NASDAQ:ACRS) will post earnings of ($0.29) per share for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Aclaris Therapeutics’ earnings, with the lowest EPS estimate coming in …